Epigenotypes of latent herpesvirus genomes

Current Topics in Microbiology and Immunology

Volumn 310, Issue , 2006, Pages 61-80

  Minarovits, J ^a  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE H3; HISTONE;

CEBIDAE; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; EPSTEIN BARR VIRUS; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HOST CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; LYMPHOBLASTOID CELL LINE; LYMPHOMA; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REPORTER GENE; REVIEW; SOMATIC CELL GENETICS; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; GENETIC EPIGENESIS; GENETICS; GENOTYPE; METABOLISM; PROMOTER REGION; REGULATOR GENE; VIRUS LATENCY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 4; MUS;

DNA METHYLATION; EPIGENESIS, GENETIC; GENES, REGULATOR; GENOME, VIRAL; GENOTYPE; HERPESVIRIDAE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 4, HUMAN; HISTONES; PROMOTER REGIONS (GENETICS); VIRUS LATENCY;

EID: 33748098027     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-540-31181-5_5     Document Type: Review

References (99)

1. Adam GIR, Cui H, Miller SJ, Flam F, Ohlsson R (1996) Allele-specific in situ hybridization (ASISH) analysis: a novel technique which resolves differential usage of H19 within the same cell lineage during human placental development. Development 122:839-847
2. Adams A, Lindahl T (1975) Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci USA 72:1477-1481
3. Alcobia I, Dilao R, Parreira L (2000) Spatial associations of centromers in the nuclei of hematopoietic cells: evidence for cell-type-specific organizational patterns. Blood 95:1608-1615
4. Altiok E, Minarovits J, Hu LF, Contreras-Brodin B, Klein G, Ernberg I (1992) Host-cellphenotype-dependent control of BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus antigens 2-6. Proc Natl Acad Sci USA 89:905-909
5. Arthur JL, Scarpini CG, Connor V, Lachmann RH, Tolkowsky AM, Efstathiou S (2001) Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. J Virol 75:3885-3895
6. Bednarik DP (1996) The silencing of human immunodeficiency virus. In: Russo EA, Martienssen RA, Riggs AD (eds) Epigenetic mechanisms of gene regulation. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 547-559
7. Bhende P, Seaman W, Delecluse HJ, Kenney SC (2004) The EBV lytic switch protein Z, preferentially binds to and activates the methylated viral genome. Nat Genet 36:1099-1104
8. Brooks AR, Harkins RN, Wang P, Qian HS, Liu P, Rubanyi GM (2004) Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J Gene Med 6:395-404
9. Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fischer A (1997) Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91:845-854
10. Buschhausen G, Graessmann M, Graessmann A (1985) Inhibition of herpes simplex thymidine kinase gene expression by DNA methylation is an indirect effect. Nucleic Acids Res 13:5503-5513
11. Buschhausen G, Wittig B, Graessmann M, Graessmann A (1987) Chromatin structure is required to block transcription of the methylated herpes simplex thymidine kinase gene. Proc Natl Acad Sci USA 84:1177-1181
12. Chau CM, Lieberman PM (2004) Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 78:12308-12319
13. Chen F, Hu LF, Ernberg I, Klein G, Winberg G (1995) Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP2-B genes in nasopharyngeal carcinomas. J Gen Virol 76:131-138
14. Chen HL, Lung MM, Sham JS, Choy DT, Griffin BE, Ng MH (1992) Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology 191:193-201
15. Chen J, Ueda K, Sakakibara S, Okuno T, Parravicini C, Corbellino M, Yamanishi K (2001) Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc Natl Acad Sci USA 98:4119-4124
16. Christy B, Scangos G (1982) Expression of transfected thymidine kinase genes is controlled by methylation. Proc Natl Acad Sci USA 79:6299-6303
17. Contreras-Brodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG (1991) B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA2-to EBNA-6: studies with somatic cell hybrids. J Gen Virol 72:3025-3033
18. de Jesus O, Smith PR, Spender LC, Karstegl CE, Niller HH, Huang D, Farrell PJ (2003) Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol 84:1443-1450
19. Decaussin G, Sbih-Lammali F, de Turenne-Tessier M, Bouguermouh A, Ooka T (2000) Expression of BARF 1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res 60:5584-5588
20. Deshamne SL, Fraser NW (1989) During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J Virol 63:943-947
21. Desrosiers RC (1982) Specifically unmethylated cytidylic-guanylate sites in herpesvirus saimiri DNA in tumor cells. J Virol 43:427-435
22. Desrosiers RC, Mulder C, Fleckenstein B (1979) Methylation of herpesvirus saimiri DNA in lymphoid tumor cell lines. Proc Natl Acad Sci USA 76:3839-3843
23. Dobson AT, Sedarati F, Devi-Rao G, Flanagan WM, Farrell MJ, Stevens JG, Wagner EK, Feldman LT (1989) Identification of the latency-associated transcript promoter by expression of beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J Virol 63:3844-3851
24. Dressler GR, Rock DL, Fraser NW (1987) Latent herpes simplex virus type I DNA is not extensively methylated in vivo. J Gen Virol 68:1761-1765
25. Egger G, Liang G, Jones P (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457-463
26. Ehrlich M (2003) Expression of various genes is controlled by DNA methylation during mammalian development. J Cell Biochem 88:899-910
27. Elliott J, Goodhew EB, Krug LT, Shakhnovsky N, Yoo L, Speck SH (2004) Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines. J Virol 78:14602-14605
28. Falk KI, Szekely L, Aleman A, Ernberg I (1998) Specific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP1-coding upstream regulatory region and an origin of DNA replication (oriP). J Virol 72:2969-2974
29. Forejt J, Saam JR, Gregorova S, Tilgham SM (1999) Monoallelic expression of reactivated imprinted genes in embryonal carcinoma cell hybrids. Exp Cell Res 252:416-422
30. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89:1827-1831
31. Honess RW, Gompels UA, Barrell BG, Craxton M, Cameron KR, Staden R, Chang YN, Hayward GS (1989) Deviations from expected frequencies of CpG dinucleotides in herpesvirus DNAs may be diagnostic of differences in the states of their latent genomes. J Gen Virol 70:837-855
32. Hu LF, Minarovits J, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I (1991) Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5′ flanking region. J Virol 65:1558-1567
33. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T (1994) Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131-9135
34. Jaenisch R, Schnieke A, Harbers K (1985) Treatment of mice with 5-azacytidine activates silent retroviral genomes in different tissues. Proc Natl Acad Sci USA 82:1451-1455
35. Jankelevich S, Kolman JL, Bodnar JW, Miller G (1992) A nuclear attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. EMBO J 11:1165-1176
36. Jansson A, Masucci M, Rymo L (1992) Methylation at discrete sites within the enhancer region regulate the activity of the Epstein-Barr virus BamJI W promoter in Burkitt lymphoma lines. J Virol 66:62-69
37. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:2889-2897
38. Jin XW, Speck SH (1992) Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. J Virol 66:2846-2852
39. Kanamori A, Ikuta K, Shigeharu U, Kato S, Hirai K (1987) Methylation of Marek's disease virus DNA in chicken T-lymphoblastoid cell lines. J Gen Virol 68:1485-1490
40. Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes S, Gallimore PH, Rickinson AB (1992) Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of promoter usage. Virology 187:189-201
41. Klein G (1996) EBV-B cell interactions: immortalization, rescue from apoptosis, tumorigenicity. Acta Microbiol Immunol Hung 43:97-105
42. Kosak ST, Skok JA, Medina KL, Riblet R, Le Beau MM, Fischer AG, Singh H (2002) Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296:158-162
43. Kubat NJ, Tran RK, McAnany P, Bloom DC (2004a) Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression. J Virol 78:1139-1149
44. Kubat NJ, Amelio AL, Giordani NV, Bloom DC (2004b) The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription. J Virol 78:12508-12518
45. Levine SS, King IF, Kingston RE (2004) Division of labour in Polycomb group repression. Trends Biochem Sci 29:479-485
46. Li H, Minarovits J (2003) Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv Cancer Res 89:133-156
47. Li Q, Peterson KR, Fang X, Stamatoyannopoulos G (2002) Locus control regions. Blood 100:3077-3086
48. Liebowitz D (1998) Pathogenesis of Epstein-Barr virus. In: McCance DJ (ed) Human tumor viruses. ASM Press, Washington, pp 175-199
49. Ling PD, Hsieh JD, Ruf IK, Rawlins DE, Hayward SD (1994) EBNA-2 upregulation of Epstein-Barr virus promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J Virol 68:5375-5383
50. Lokensgard JR, Bloom DC, Dobson AT, Feldman LT (1994) Long-term promoter activity during herpes simplex virus latency. J Virol 68:7148-7158
51. Longnecker R (1998) Molecular biology of Epstein-Barr virus. In: McCance DJ (ed) Human tumor viruses. ASM Press, Washington, pp 135-174
52. Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Ernberg I, Klein G (1989) 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line Rael. J Virol 63:3135-3141
53. McGeoch DJ, Davison AJ (1999) The molecular history of herpesviruses. In: Domingo E, Webster R, Holland J (eds) Origin and evolution of viruses. Academic Press, New York, pp 441-465
54. Mellerick DM, Fraser NW (1987) Physical state of the latent herpes simplex virus genomein amousemodel system: evidence suggesting an episomal state. Virology 158:265-275
55. Minarovits J, Minarovits-Kormuta S, Ehlin-Henriksson B, Falk K, Klein G, Ernberg I (1991) Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. J Gen Virol 72:1591-1599
56. Minarovits J, Hu LF, Marcsek Z, Minarovits-Kormuta S, Klein G, Ernberg I (1992) RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus carrying cell types. J Gen Virol 73:1687-1692
57. Minarovits J, Hu LF, Imai S, Harabuchi Y, Kataura A, Minarovits-Kormuta S, Osato T, Klein G (1994) Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J Gen Virol 75:77-84
58. Mitsuya K, Sui H, Meguro M, Kugoh H, Jinno Y, Niikawa N, Oshimura M (1997) Paternal expression of WT1 in human fibroblasts and lymphocytes. Hum Mol Genet 6:2243-2246
59. Morimura T, Ohashi K, Sugimoto C, Onuma M (1998) Pathogenesis of Marek's disease (MD) and possible mechanism of immunity induced by MD vaccine. J Vet Med Sci 60:1-8
60. Niller HH, Salamon D, Takacs M, Uhlig J, Wolf H, Minarovits J (2001) Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines. Biol Chem 382:1411-1419
61. Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Bäml G, Rücker OL, Schwarzmann F, Wolf H, Minarovits J (2003) The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med Sci Monit 9:HY1-HY9
62. Niller HH, Salamon D, Rahmann S, Ilg K, Koroknai A, Bánáti F, Schwarzmann F, Wolf H, Minarovits J (2004a) A 30 kb region of the Epstein-Barr virus genome is colinear with the rearranged human immunoglobulin gene loci: implications for a "ping-pong evolution" model for persisting viruses and their hosts. Acta Microbiol Immunol Hung 51:469-484
63. Niller HH, Salamon D, Banati F, Schwarzmann F, Wolf H, Minarovits J (2004b) The LCR of EBV makes Burkitt's lymphoma endemic. Trends Microbiol 12:495-499
64. Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Schwarzmann F, Wolf H, Minarovits J (2004c) EBV-associated neoplasms: alternative pathogenetic pathways. Med Hypotheses 62:387-391
65. Nonoyama M, Pagano JS (1972) Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus producing cells. Nature 238:169-171
66. Obata Y, Kono T (2002) Maternal primary imprinting is established at a specific time for each gene throughout oocyte growth. J Biol Chem 277:5285-5289
67. Prosch S, Stein J, Staak K, Liebenthal C, Volk HD, Kruger DH (1996) Inactivation of the very strong HCMV immediate early promoter by CpG methylation in vitro. Biol Chem Hoppe Seyler 377:195-201
68. Robertson KD, Hayward SD, Ling PD, Samid D, Ambinder R (1995) Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol 15:6150-6159
69. Sadler RH, Raab-Traub N (1995) The Epstein-Barr virus 3.5-kilobase latent membrane protein mRNA initiates from a TATA-less promoter within the first terminal repeat. J Virol 69:4577-4581
70. Saitoh S, Buiting K, Rogan PK, Buxton JL, Driscoll DJ, Arnemann J, König R, Malcolm S, Horsthemke B (1996) Minimal definition of the imprinting center and fixation of a chromosome 15q11-13 epigenotype by imprinting mutations. Proc Natl Acad Sci USA 93:7811-7815
71. Salamon D, Takacs M, Myöhänen S, Marcsek Z, Berencsi G, Minarovits J (2000) De novo methylation at nonrandom founder sites 5′ from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes. Biol Chem 381:95-105
72. Salamon D, Takacs M, Ujvari D Uhlig J, Wolf H, Minarovits J, Niller HH (2001) Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp and LMP1p of Epstein-Barr virus. J Virol 75:2584-2596
73. Salamon D, Takacs M, Schwarzmann F, Wolf H, Minarovits J, Niller HH (2003) High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes. Virus Genes 27:57-66
74. Sano M, Kitayama S (1996) Inhibition of nerve growth factor-induced outgrowth of neurites by trichostatin A requires de novo protein synthesis in PC12D cells. Brain Res 742:195-202
75. Santoso B, Ortiz BD, Winoto A (2000) Control of organ-specific demethylation by an element of the T-cell receptor-α locus control region. J Biol Chem 275:1952-1958
76. Schaefer BC, Strominger JL, Speck SH (1997) Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs. Mol Cell Biol 17:364-377
77. Sjöblom-Hallén A, Yang W, Jansson A, Rymo L (1999) Silencing the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure. J Virol 73:2983-2993
78. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT (1987) RNA complementary to a herpesvirus alpha gene mRNA prominent in latently infected neurons. Science 235:1056-1059
79. Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose R, Armitage SJ, Spriggs MK (1998) The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol 72:4015-4021
80. Su A, Wiltshire T, Batalov S, Lapp H, Ching K, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke M, Walker JR, Hogenesch JB (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101:6062-6067
81. Sung NS, Kenney S, Gutsch D, Pagano JS (1991) EBNA-2 transactivates a lymphoid specific enhancer in the BamHI-Cpromoter of Epstein-Barr virus. J Virol 65:2164-2169
82. Sutter D, Doerfler W (1980) Methylation of integrated adenovirus type 12 DNA sequences in transformed cells is inversely correlated with gene expression. Proc Natl Acad Sci USA 77:253-256
83. Takacs M, Myöhänen S, Altiok E, Minarovits J (1998) Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing. Biol Chem 379:417-422
84. Takacs M, Salamon D, Myöhänen S, Li H, Segesdi J, Ujvari D, Uhlig J, Niller HH, Wolf H, Berencsi G, Minarovits J (2001a) Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes. Biol Chem 382:699-705
85. Takacs M, Segesdi J, Balog K, Mezei M, Tóth G, Minárovits J (2001b) Relative deficiency in CpG dinucleotides is a wide spread but not unique feature of Gammaherpesvirinae genomes. Acta Microbiol Immunol Hung 48:349-357
86. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF (1998) The Epstein-Barr virus latent promoter Q is constitutively active, hypomethylated and methylation sensitive. J Virol 72:7075-7083
87. Tao Q, Huang H, Geiman TM, Lim CY, Fu L, Qiu GH, Robertson KD (2002) Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet 11:2091-9102
88. Tasseron-de Jong JG, den Dulk H, van de Putte P, Giphart-Gassler M (1989) De novo methylation is a major event in the inactivation of transfected herpesvirus thymidine kinase genes in human cells. Biochim Biophys Acta 1007:215-223
89. Tierney RJ, Kirby HE, Nagra JK, Desmond J, Bell AI, Rickinson AB (2000) Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter downregulation during virus-induced B-cell transformation. J Virol 74:10468-10479
90. Toth M, Muller U, Doerfler W (1990) Establishment of de novo DNA methylation patterns. Transcription factor binding and non-CpG sequences in an integrated adenovirus promoter. J Mol Biol 214:673-683
91. Vardimon L, Newmann R, Kuhlmann I, Sutter D, Doerfler W (1980) DNA methylation and viral gene expression in adenovirus transformed and infected cells. Nucleic Acids Res 8:2461-2473
92. Welch HM, Bridges CG, Lyon AM, Griffiths L, Edington N (1992) Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues. J Gen Virol 73:261-268
93. Wettstein FO, Stevens JG (1983) Shope papilloma virus DNA is extensively methylated in non-virus-producing neoplasms. Virology 126:493-504
94. Whitelaw E, Martin DIK (2001) Retrotransposons as epigenetic mediators of phenotypic variation in mammals. Nat Genet 27:361-365
95. Woisetschlaeger M, Yandava C, Fumarsky L, Strominger J, Speck S (1990) Promoter-switching in Epstein-Barr virus during the initial infection in B lymphocytes. Proc Natl Acad Sci USA 87:1725-1729
96. Wolffe AP, Matzke MA (1999) Epigenetics: regulation through repression. Science 286:481-486
97. Yoshioka M, Kikuta H, Ishiguro N, Ma X, Kobayashi K (2003a) Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection. J Gen Virol 84:1133-1140
98. Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K (2003b) Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. J Med Virol 70:410-419
99. Youssoufian H, Hammer SM, Hirsch MS, Mulder M (1982) Methylation of the viral genome in an in vitro model of herpes simplex virus latency. Proc Natl Acad Sci USA 79:2207-2210